Kathrin Neumann

Kathrin Neumann

Auto-generated profile, based on publicly available information

Kathrin Neumann

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich , Zurich 8091

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
NBNadine Bachmann
Nadine Bachmann
CSChantal von Siebenthal
Chantal von Siebenthal
VVValentina Vongrad
Valentina Vongrad
TTTeja Turk
Teja Turk
KNKathrin Neumann
Kathrin Neumann
KMKarin Metzner
Karin Metzner
The HIV-1 reservoir is the major hurdle to a cure. We here evaluate viral and host characteristics associated with reservoir size and long-term dynamics in 1,057 individuals on suppressive antiretroviral therapy for a median of 5.4 years. At the population level, the reservoir decreases with diminishing differences over time, but increases in 26.6% of individuals. Viral blips and low-level viremia are significantly associated with slower reservoir decay. Initiation of ART within the first year of infection, pretreatment viral load, and ethnicity affect reservoir size, but less so long-term dynamics. Viral blips and low-level viremia are thus relevant for reservoir and cure studies.

10 May 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
YKYik Lim Kok
Yik Lim Kok
VVValentina Vongrad
Valentina Vongrad
SCSandra E. Chaudron
Sandra E. Chaudron
MSMohaned Shilaih
Mohaned Shilaih
CLChristine Leemann
Christine Leemann
KMKarin Metzner
Karin Metzner
HIV-1 is capable of integrating its genome into that of its host cell. We examined the influence of the activation state of CD4 + T cells, the effect of antiretroviral therapy (ART), and the clinical stage of HIV-1 infection on HIV-1 integration site features and selection. HIV-1 integration sites were sequenced from longitudinally sampled resting and activated CD4 + T cells from 12 HIV-1–infected individuals. In total, 589 unique HIV-1 integration sites were analyzed: 147, 391, and 51 during primary, chronic, and late presentation of HIV-1 infection, respectively. As early as during primary HIV-1 infection and independent of the activation state of CD4 + T cells collected on and off ART, HIV-1 integration sites were preferentially detected in recurrent integration genes, genes associated with clonal expansion of latently HIV-1–infected CD4 + T cells, cancer-related genes, and highly expressed genes. The preference for cancer-related genes was more pronounced at late stages of HIV-1 infection. Host genomic features of HIV-1 integration site selection remained stable during HIV-1 infection in both resting and activated CD4 + T cells. In summary, characteristic HIV-1 integration site features are preestablished as early as during primary HIV-1 infection and are found in both resting and activated CD4 + T cells.

2 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CWChenjie Wan
Chenjie Wan
NBNadine Bachmann
Nadine Bachmann
VMVenelin Mitov
Venelin Mitov
FBFrançois Blanquart
François Blanquart
SCSusana Posada Céspedes
Susana Posada Céspedes
RKRoger D. Kouyos
Roger D. Kouyos
The HIV-1 reservoir is the major hurdle to curing HIV-1. However, the impact of the viral genome on the HIV-1 reservoir, i.e. its heritability, remains unknown. We investigate the heritability of the HIV-1 reservoir size and its long-term decay by analyzing the distribution of those traits on viral phylogenies from both partial-pol and viral near full-length genome sequences. We use a unique nationwide cohort of 610 well-characterized HIV-1 subtype-B infected individuals on suppressive ART for a median of 5.4 years. We find that a moderate but significant fraction of the HIV-1 reservoir size 1.5 years after the initiation of ART is explained by genetic factors. At the same time, we find more tentative evidence for the heritability of the long-term HIV-1 reservoir decay. Our findings indicate that viral genetic factors contribute to the HIV-1 reservoir size and hence the infecting HIV-1 strain may affect individual patients’ hurdle towards a cure.

4 March 2021 in Viruses
Verified
Journal Article
Open access
PDF file
ARAudrey E. Rindler
Audrey E. Rindler
HKHerbert Kuster
Herbert Kuster
KNKathrin Neumann
Kathrin Neumann
CLChristine Leemann
Christine Leemann
DBDominique L Braun
Dominique L Braun
HGHuldrych Günthard
Huldrych Günthard
HIV-1 replication capacity is an important characteristic to understand the replication competence of single variants or virus populations. It can further aid in the understanding of HIV-1 pathogenicity, disease progression, and drug resistance mutations. To effectively study RC, many assays have been established. However, there is still demand for a high throughput replication capacity assay using primary cells which is robust and reproducible. In this study, we established such an assay and validated it using 346 primary HIV-1 isolates from patients enrolled in the Zurich Primary HIV Infection study (ZPHI) and two control viruses, HIV-1 JR-CSFWT and HIV-1 JR-CSFK65R_M184V. Replication capacity was determined by measuring the viral growth on PBMCs over 10 days by longitudinally transferring cell culture supernatant to TZM-bl reporter cells. By utilizing the TZM-bl luciferase reporter assay, we determined replication capacity by measuring viral infectivity. The simplicity of the experimental setup allowed for all 346 primary HIV-1 isolates to be replicated at one time. Although the infectious input dose for each virus was normalized, a broad range of replication capacity values over 4 logs was observed. The approach was confirmed by two repeated experiments and we demonstrated that the reproducibility of the replication capacity values is statistically comparable between the two separate experiments. In summary, these results endorse our high throughput replication capacity assay as reproducible and robust and can be utilized for large scale HIV-1 replication capacity experiments in primary cells.

24 November 2020 in PeerJ
Verified
Journal Article
Open access
PDF file
AIAnne Inderbitzin
Anne Inderbitzin
YKYik Lim Kok
Yik Lim Kok
LJLisa Jörimann
Lisa Jörimann
AKAudrey Kelley
Audrey Kelley
KNKathrin Neumann
Kathrin Neumann
KMKarin Metzner
Karin Metzner
Background: The persistence of the latent HIV-1 reservoir is a major obstacle to curing HIV-1 infection. HIV-1 integrates into the cellular genome and some targeted genomic loci are frequently detected in clonally expanded latently HIV-1 infected cells, for instance, the geneBTB domain and CNC homology 2 (BACH2).Methods: We investigated HIV-1 promoter activity after integration into specific sites inBACH2in Jurkat T-cells. The HIV-1-based vector LTatCL[M] contains two fluorophores: (1) Cerulean, which reports the activity of the HIV-1 promoter and (2) mCherry driven by a constitutive promotor and flanked by genetic insulators. This vector was inserted into introns 2 and 5 ofBACH2of Jurkat T-cells via CRISPR/Cas9 technology in the same and convergent transcriptional orientation ofBACH2, and into the genomic safe harbour AAVS1. Single cell clones representing active (Cerulean+/mCherry+) and inactive (Cerulean–/mCherry+) HIV-1 promoters were characterised.Results: Upon targeted integration of the 5.3 kb vector LTatCL[M] intoBACH2, the HIV-1 promoter was gradually silenced as reflected by the decrease in Cerulean expression over a period of 162 days. Silenced HIV-1 promoters could be reactivated by TNF-α and Romidepsin. This observation was independent of the targeted intron and the transcriptional orientation.BACH2mRNA and protein expression was not impaired by mono-allelic integration of LTatCL[M].Conclusion: Successful targeted integration of the HIV-1-based vector LTatCL[M] allows longitudinal analyses of HIV-1 promoter activity.

6 December 2019 in medRxiv
Verified
Preprint
Open access
PDF file
CTChristian W. Thorball
Christian W. Thorball
ABAlessandro Borghesi
Alessandro Borghesi
NBNadine Bachmann
Nadine Bachmann
CSChantal von Siebenthal
Chantal von Siebenthal
VVValentina Vongrad
Valentina Vongrad
TSthe Swiss HIV Cohort Study
the Swiss HIV Cohort Study
Introduction: A major hurdle to HIV-1 eradication is the establishment of a latent viral reservoir early after primary infection. Several factors are known to influence the HIV-1 reservoir size and decay rate on suppressive antiretroviral treatment (ART), but little is known about the role of human genetic variation. Methods: We measured the reservoir size at three time points over a median of 5.4 years, and searched for associations between human genetic variation and two phenotypic readouts: the reservoir size at the first time point and its decay rate over the study period. We assessed the contribution of common genetic variants using genome-wide genotyping data from 797 patients with European ancestry enrolled in the Swiss HIV Cohort Study and searched for a potential impact of rare variants and exonic copy number variants using exome sequencing data generated in a subset of 194 study participants. Results: Genome- and exome-wide analyses did not reveal any significant association with the size of the HIV-1 reservoir or its decay rate on suppressive ART. Conclusions: Our results point to a limited influence of human genetics on the size of the HIV-1 reservoir and its long-term dynamics in successfully treated individuals.